Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Other Operating Income - Additional Information (Details)

v3.22.4
Other Operating Income - Additional Information (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of attribution of expenses by nature to their function [line items]      
Other operating income € 18,850 € 9,386 € 5,230
Other operating income related to contract modifications 7,600    
Contribution of joint development 3,000    
Miscellaneous other operating income   9,210 4,958
Nuova Ompi S.r.l.      
Disclosure of attribution of expenses by nature to their function [line items]      
Grants received by subsidiaries     272
Grants received as tax credit 6 28 28
Grants related to sustainable growth fund     € 244
Ompi Pharma Packaging Tech. Co Ltd      
Disclosure of attribution of expenses by nature to their function [line items]      
Grants received for machinery technical renovation 150 106  
Ompi Pharma Packaging Tech. Co Ltd and Nuova Ompi S.r.l.      
Disclosure of attribution of expenses by nature to their function [line items]      
Grants received by subsidiaries € 156 € 176